The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125352661 12535266 1 I 20120501 20160707 20160707 EXP JP-CIPLA LTD.-2012JP00485 CIPLA TERASAKI M, BOUFFET E, MAEDA M, SUGITA Y, SAWAMURA Y, MORIOKA M. SUCCESSFUL TREATMENT OF LEPTOMENINGEAL GLIOMATOSIS OF PILOMYXOID ASTROCYTOMA AFTER FAILED FRONTLINE CHEMOTHERAPY. THE NEUROLOGIST. 2012;18:32 TO 35 5.00 YR M Y 0.00000 20160707 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125352661 12535266 1 PS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) 175 MG/M2, ON DAYS 0, 7, 14, 21, 42, 49, 56, AND 63 Y U 0 175 MG/M**2 INFUSION
125352661 12535266 2 SS Vincristine VINCRISTINE 1 Intravenous bolus 1.5 MG/M2 ON DAYS 0, 7, 14, 21, 28, 35, 42, 49, 56, AND 63 Y U 0 1.5 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125352661 12535266 1 Astrocytoma
125352661 12535266 2 Astrocytoma

Outcome of event

Event ID CASEID OUTC COD
125352661 12535266 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125352661 12535266 Coma
125352661 12535266 Disease progression
125352661 12535266 Hydrocephalus
125352661 12535266 Treatment failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found